Skip to main content

MoneyWorks4Me

Lupin informs about updates

02 Apr 2024 Evaluate
Lupin has informed that as Para 2.2 viz. ‘Applicability of Framework’ of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, is not applicable to the Company, it shall not be considered as 'Large Corporate'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1906.55
Dr. Reddys Labs. 1380.20
Cipla 1403.95
Lupin 2007.00
Zydus Lifesciences 1212.45
View more..